Drug recall · April 30, 2014
Oxandrolone Tablets recall
Why: Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper, labeled with the correct shipper bar code label, sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs, Minneapolis, MN 55447, by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 0245-0272-06
- Lots / codes
Lot #2802.042A, Exp. 10/2015
- Quantity
- 1,185 bottles
- Company
- Upsher Smith Laboratories, Inc., Maple Grove, MN
- Distribution
- Nationwide
- Initiated
- April 14, 2014 · Voluntary: Firm initiated
- Classified
- April 23, 2014
- Reported
- April 30, 2014
- Ended
- July 1, 2014
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.